MindWalk Holdings (HYFT) Assets Average (2020 - 2026)
MindWalk Holdings (HYFT) reported Assets Average of $17.7 million for Q1 2026, down 53.44% year-over-year from $38.0 million in Q1 2025, and down 27.01% quarter-over-quarter from $24.2 million in Q4 2025.
MindWalk Holdings (HYFT) Assets Average (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Assets Average data on file, last reported at $17.7 million in Q1 2026.
- Assets Average for Q1 2026 came in at $17.7 million, down 53.44% year-over-year; the trailing twelve-month figure through Jan 2026 was $17.7 million (down 53.44% YoY), and the FY2025 annual result was $38.1 million, down 25.16% from the prior year.
- Assets Average slipped to $17.7 million in Q1 2026 per HYFT's latest filing, from $24.2 million in the prior quarter.
- Over five years, Assets Average peaked at $68.0 million in Q3 2022 and troughed at $17.7 million in Q1 2026.
- A 5-year average of $47.6 million and a median of $51.2 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2026: Assets Average jumped 38.3% in 2022, then plunged 53.44% in 2026.
- A 5-year view of Assets Average shows it stood at $62.2 million in 2022, then dropped by 9.1% to $56.6 million in 2023, then retreated by 22.91% to $43.6 million in 2024, then tumbled by 44.42% to $24.2 million in 2025, then retreated by 27.01% to $17.7 million in 2026.
- Business Quant data shows HYFT's Assets Average at $17.7 million in Q1 2026, $24.2 million in Q4 2025, and $30.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 660.38 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 17.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 17.69 Mn |
| Oct 31, 2025 | 24.24 Mn |
| Jul 31, 2025 | 30.44 Mn |
| Apr 30, 2025 | 31.65 Mn |
| Jan 31, 2025 | 37.99 Mn |
| Oct 31, 2024 | 43.61 Mn |
| Jul 31, 2024 | 43.77 Mn |
| Apr 30, 2024 | 51.22 Mn |
| Jan 31, 2024 | 56.98 Mn |
| Oct 31, 2023 | 56.57 Mn |
| Jul 31, 2023 | 57.44 Mn |
| Apr 30, 2023 | 59.31 Mn |
| Jan 31, 2023 | 61.71 Mn |
| Oct 31, 2022 | 62.23 Mn |
| Jul 31, 2022 | 68.05 Mn |
| Apr 30, 2022 | 59.27 Mn |
| Jan 31, 2022 | 46.29 Mn |
| Oct 31, 2021 | 50.22 Mn |
| Jul 31, 2021 | 52.82 Mn |
| Apr 30, 2021 | 43.54 Mn |